Samuel L Moore

Title: Inventor Spotlight: Samuel L Moore from Sykesville, MD

Introduction

Samuel L Moore is an innovative inventor based in Sykesville, Maryland, known for his contributions to immunological research and health technology. With a total of three patents to his name, he focuses on enhancing the understanding and management of immune health within populations.

Latest Patents

One of his latest patents is titled "Automated systems and methods for obtaining, storing, processing and utilizing immunologic information of an individual or population for various uses." This patent details a system and method for assessing the immunological status of individuals in a patient population. It involves establishing a comprehensive database of immune status records, incorporating current biochemical assay information alongside individual medical histories and demographic data. The processing of this information is aimed at identifying trends or patterns that can inform healthcare decisions related to immunological statuses.

Similarly, Moore's second patent underlines the same innovative approach to understanding and utilizing immunological data for better healthcare outcomes, reiterating the importance of technology in the field of medicine.

Career Highlights

Samuel L Moore currently works at Wellstat Vaccines, LLC, a company dedicated to advancing vaccine technology and immunotherapeutics. His work there emphasizes his commitment to improving public health through the application of scientific research and innovative medical practices.

Collaborations

Throughout his career, Samuel has collaborated with talented coworkers such as Francis Michon and Samuel J Wohlstadter. These partnerships have enriched his professional journey and contributed significantly to his innovative projects in immunology.

Conclusion

Samuel L Moore’s dedication to advancing immunological health through innovative technology sets a remarkable example in the field of invention. His patents reflect a forward-thinking approach and a commitment to improving healthcare through data-driven methodologies. With continued collaborations and a focus on impactful research, he remains a significant contributor to advancements in the biomedical sector.